Comprehensive Pharmacognostic and Pharmacological Analysis of Calotropis procera

Comprehensive Pharmacognostic and Pharmacological Analysis of Calotropis procera

• 1.
  Calotropis procera (Aiton)W.T. Aiton: Pharmacognostic Characterization, Phytochemical Profile, Mechanism- Based Pharmacology, Toxicology, and Pharmaceutical Applications BAASIR UMAIR KHATTAK (MPhil in Pharmacology)
• 2.
  1 CALOTROPIS PROCERA (AITON)W.T. AITON: PHARMACOGNOSTIC CHARACTERIZATION, PHYTOCHEMICAL PROFILE, MECHANISM-BASED PHARMACOLOGY, TOXICOLOGY, AND PHARMACEUTICALAPPLICATIONS 1. Introduction Calotropis procera (Aiton) W.T. Aiton, commonly known as Sodom apple or Giant milkweed and locally referred to as Aak or Madar (Urdu/Hindi) and Arka (Sanskrit), is a perennial medicinal shrub belonging to the family Apocynaceae. The plant is characterized by its abundant milky latex, which contains a diverse range of bioactive secondary metabolites including cardenolides, flavonoids, terpenoids, steroids, phenolic compounds, and proteolytic enzymes. Although traditionally employed in Ayurveda, Unani, African, and Middle Eastern medicine for the treatment of inflammatory disorders, skin diseases, gastrointestinal ailments, asthma, diabetes, wound healing, and parasitic infections, the plant possesses significant inherent toxicity due primarily to its cardiac glycosides. Recent pharmacological investigations have demonstrated anti- inflammatory, antioxidant, antimicrobial, anticancer, hepatoprotective, immunomodulatory, and wound-healing activities. However, despite encouraging in vitro and in vivo findings, the majority of evidence remains preclinical, and standardized clinical evaluation is still lacking. Recent reviews emphasize the need for phytochemical standardization, mechanistic studies, and translational research before clinical application 2. Botanical Classification and Pharmacognostic Identification Botanical Classification Taxonomic Rank Classification Kingdom Plantae Division Magnoliophyta Class Magnoliopsida
• 3.
  2 CALOTROPIS PROCERA (AITON)W.T. AITON: PHARMACOGNOSTIC CHARACTERIZATION, PHYTOCHEMICAL PROFILE, MECHANISM-BASED PHARMACOLOGY, TOXICOLOGY, AND PHARMACEUTICALAPPLICATIONS Taxonomic Rank Classification Order Gentianales Family Apocynaceae Subfamily Asclepiadoideae Genus Calotropis Species Calotropis procera (Aiton) W.T. Aiton Pharmacognostic Identification The plant is an erect perennial shrub (2–5 m) with thick grey-green succulent stems containing abundant white latex. Leaves are opposite, sessile, ovate-oblong, thick, glabrous, and covered by a waxy cuticle. Flowers are pentamerous, white to purple, arranged in umbellate cymes, while fruits are inflated follicles containing numerous compressed brown seeds with silky comose hairs. Microscopically, the leaves exhibit dorsiventral anatomy with anisocytic stomata, multicellular laticifers, abundant calcium oxalate crystals, and collateral vascular bundles. Powder microscopy demonstrates lignified xylem vessels, latex ducts, calcium oxalate prisms, spiral vessels, starch granules, and parenchymatous cells, all of which are useful pharmacognostic markers for quality control. 3. Plant Parts Used Nearly every part of C. procera has been investigated pharmacologically.  Leaves: anti-inflammatory, antioxidant, antimicrobial, antidiabetic, wound healing.  Latex: richest source of cardenolides and proteolytic enzymes; investigated for anticancer, antimicrobial, fibrinolytic, and wound-healing applications but also responsible for most toxic effects.  Root bark: anti-inflammatory, analgesic, hepatoprotective, antimicrobial, and anticancer activities.  Stem bark: antimicrobial and antioxidant activities.  Flowers: flavonoid-rich; evaluated for antioxidant and anti-inflammatory potential.  Seeds: contain cardenolides and fixed oils with reported antifertility and antimicrobial activities.
• 4.
  3 CALOTROPIS PROCERA (AITON)W.T. AITON: PHARMACOGNOSTIC CHARACTERIZATION, PHYTOCHEMICAL PROFILE, MECHANISM-BASED PHARMACOLOGY, TOXICOLOGY, AND PHARMACEUTICALAPPLICATIONS Among these, latex and root bark contain the highest concentrations of cardiac glycosides, whereas leaves are comparatively richer in flavonoids and phenolic compounds. 4. Comprehensive Phytochemistry More than 150 phytochemicals have been reported from C. procera. Major classes include cardenolides, flavonoids, terpenoids, sterols, oxypregnanes, phenolic acids, alkaloids, glycosides, and proteolytic enzymes. Reported concentrations vary considerably according to geographical origin, season, plant age, solvent system, and analytical technique; therefore, no single universal percentage composition exists. Major constituents include: Phytochemical class Representative compounds Predominant plant part Cardenolides Calotropin, Calotoxin, Calactin, Uscharin, Uscharidin, Frugoside, Proceragenin Latex, root bark, seeds Flavonoids Quercetin, Kaempferol, Isorhamnetin, Rutin Leaves, flowers Terpenoids Lupeol, α-amyrin, β-amyrin, Taraxasterol Latex, flowers, root bark Sterols β-Sitosterol, Stigmasterol Latex, bark Phenolic acids Gallic acid, Chlorogenic acid, Ferulic acid, Caffeic acid Leaves Proteins Calotropain I, Calotropain II Latex Cardenolides constitute the pharmacologically dominant class and are responsible for both therapeutic and toxicological effects. Flavonoids contribute largely to antioxidant and anti- inflammatory activity, whereas proteolytic enzymes facilitate wound debridement and tissue remodeling. 5. Extraction Methodologies Extraction procedures differ according to plant part and intended phytochemical class. Leaves are generally shade dried or oven dried (40–45 °C), pulverized, and extracted by maceration, Soxhlet extraction, reflux, ultrasound-assisted extraction, or microwave-assisted extraction using water, ethanol, methanol, hydroethanol, acetone, or chloroform. The concentrated extracts are obtained by rotary evaporation followed by freeze-drying or vacuum drying.
• 5.
  4 CALOTROPIS PROCERA (AITON)W.T. AITON: PHARMACOGNOSTIC CHARACTERIZATION, PHYTOCHEMICAL PROFILE, MECHANISM-BASED PHARMACOLOGY, TOXICOLOGY, AND PHARMACEUTICALAPPLICATIONS Fresh latex is collected by stem incision, filtered to remove debris, and either processed directly or fractionated with hexane, dichloromethane, ethyl acetate, n-butanol, and aqueous solvents to isolate lipophilic cardenolides and other secondary metabolites. Root bark, stem bark, flowers, and seeds are generally dried, powdered, and extracted with methanol or ethanol by Soxhlet or cold maceration before phytochemical analysis using HPLC, LC-MS/MS, GC-MS, FTIR, or NMR spectroscopy. Modern extraction methods increasingly employ ultrasound-assisted extraction and microwave-assisted extraction to improve yield while minimizing thermal degradation. 6. Mechanism-Based Pharmacology The pharmacological effects of C. procera are largely mediated through cardenolides and flavonoids. Cardenolides bind to the extracellular domain of Na⁺/K⁺-ATPase, inhibiting ion transport and increasing intracellular sodium concentration. Reduced sodium extrusion decreases Na⁺/Ca²⁺ exchanger activity, leading to intracellular calcium accumulation and enhanced sarcoplasmic reticulum calcium storage. While moderate calcium elevation produces positive inotropy, excessive accumulation induces mitochondrial calcium overload, oxidative stress, mitochondrial permeability transition pore opening, cytochrome-c release, apoptosome formation, caspase-9 and caspase-3 activation, and apoptosis. Na⁺/K⁺-ATPase also functions as a signaling receptor. Cardenolide binding activates Src kinase, transactivates EGFR, and modulates Ras/Raf/MEK/ERK signaling. Additional effects include inhibition of PI3K/Akt/mTOR signaling, activation of JNK and p38 MAPK pathways, suppression of NF-κB, inhibition of STAT3 and HIF-1α, downregulation of VEGF, MMP-2, and MMP-9, and induction of autophagy through Beclin-1 and LC3-II. Flavonoids activate Nrf2 while suppressing NF-κB, thereby enhancing antioxidant enzyme expression (SOD, catalase, glutathione peroxidase) and reducing pro-inflammatory mediators such as TNF-α, IL-1β, IL-6, COX-2, and iNOS. 7. Evidence-Based Pharmacology Experimental evidence supports a broad spectrum of biological activities. Anti-inflammatory effects have been demonstrated through inhibition of NF-κB, COX-2, LOX, and inflammatory cytokines. Antioxidant activity is mediated through activation of the Nrf2 pathway and scavenging of reactive oxygen species. Anticancer studies have shown apoptosis induction, cell-cycle arrest, inhibition of angiogenesis, and suppression of metastatic signaling in breast, liver, colon, cervical, and lung cancer cell lines. Additional studies report antimicrobial activity against Gram-positive, Gram-negative, and fungal pathogens, antidiabetic activity through inhibition of α-glucosidase and α-amylase, wound healing through stimulation of fibroblast
• 6.
  5 CALOTROPIS PROCERA (AITON)W.T. AITON: PHARMACOGNOSTIC CHARACTERIZATION, PHYTOCHEMICAL PROFILE, MECHANISM-BASED PHARMACOLOGY, TOXICOLOGY, AND PHARMACEUTICALAPPLICATIONS proliferation and collagen deposition, and hepatoprotective activity through reduction of oxidative stress. Representative publications include:  A review on phytochemical constituents and pharmacological potential of Calotropis procera. RSC Advances (2021). DOI: 10.1039/D1RA06703F.  An overview on the phytochemical and therapeutic potential of Calotropis procera. Modern Chinese Medicine (2024). DOI: 10.1016/j.prmcm.2024.100441.  Calotropis procera: A comprehensive review of its phytochemistry, ethnomedicinal uses, and pharmacological potential. South African Journal of Botany (2025). DOI: 10.1016/j.sajb.2025.08.001. 8. Comprehensive Toxicology The latex represents the most toxic fraction of the plant. Toxicity is principally attributable to cardenolides that inhibit Na⁺/K⁺-ATPase in excitable tissues. Cardiotoxicity is characterized by intracellular calcium overload, delayed afterdepolarizations, atrioventricular block, ventricular arrhythmias, hyperkalemia, and potential cardiac arrest. Hepatotoxicity involves oxidative stress, lipid peroxidation, glutathione depletion, elevated transaminases, and hepatocellular degeneration. Nephrotoxicity manifests as tubular epithelial injury with elevated serum creatinine and urea. Ocular exposure to latex may produce keratoconjunctivitis, corneal edema, endothelial dysfunction, photophobia, and transient visual impairment. Gastrointestinal toxicity includes nausea, vomiting, abdominal pain, and diarrhea resulting from local irritation and systemic cardiac glycoside effects. Toxicological studies indicate that severity is dose dependent and influenced by the route of exposure. 9. Antidote and Management No specific antidote exists for C. procera poisoning. Management is primarily supportive and follows established principles for cardiac glycoside intoxication. Initial treatment includes gastrointestinal decontamination with activated charcoal (when appropriate), continuous ECG monitoring, correction of electrolyte abnormalities, and supportive cardiovascular care. Atropine is recommended for symptomatic bradycardia, while temporary pacing may be required for refractory atrioventricular block. Ventricular arrhythmias may be treated with lidocaine or phenytoin. In severe poisoning with life-threatening cardiac manifestations, digoxin-specific antibody fragments (Digoxin immune Fab) have been proposed based on mechanistic similarity, although evidence specific to C. procera poisoning remains limited. Ocular exposure requires immediate irrigation and ophthalmologic evaluation.
• 7.
  6 CALOTROPIS PROCERA (AITON)W.T. AITON: PHARMACOGNOSTIC CHARACTERIZATION, PHYTOCHEMICAL PROFILE, MECHANISM-BASED PHARMACOLOGY, TOXICOLOGY, AND PHARMACEUTICALAPPLICATIONS 10. Nanoformulation and Pharmaceutical Applications Recent pharmaceutical research has explored C. procera extracts in green nanotechnology and advanced drug delivery systems. Plant-mediated synthesis of silver, gold, zinc oxide, and iron oxide nanoparticles has demonstrated enhanced antimicrobial, antioxidant, and anticancer activities. Polymeric nanoparticles, liposomes, chitosan nanoparticles, PLGA nanoparticles, nanoemulsions, hydrogels, and nanostructured lipid carriers have been investigated to improve stability, bioavailability, targeted delivery, and controlled release of bioactive constituents while reducing systemic toxicity. Although promising, these formulations remain largely at the preclinical stage and require further pharmacokinetic, toxicological, and clinical evaluation. 11. Future Research Directions Future investigations should focus on phytochemical standardization, quantitative metabolomic profiling, and identification of reliable chemical markers for quality control. Comprehensive pharmacokinetic and pharmacodynamic studies are needed to establish dose-response relationships and therapeutic windows. Greater emphasis should be placed on chronic toxicity, reproductive toxicity, genotoxicity, and clinical safety assessment. Molecular investigations integrating transcriptomics, proteomics, metabolomics, and systems pharmacology may further clarify the mechanisms underlying both therapeutic efficacy and toxicity. Finally, optimization of nanoformulations, targeted drug delivery systems, and well-designed randomized clinical trials will be essential to translate the promising preclinical evidence into safe and effective pharmaceutical applications.